Caring Brands Inc. announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, an over-the-counter nausea relief product. Under the agreement, Caring Brands will assume responsibility for manufacturing, marketing, sales strategy, and global distribution of Emesyl. The agreement also includes a royalty structure based on future net sales and the potential for Caring Brands to earn equity in Itonis tied to revenue milestones. Itonis will provide technical and product information to support the commercial launch and ongoing development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caring Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9619637-en) on January 05, 2026, and is solely responsible for the information contained therein.